379 related articles for article (PubMed ID: 24703576)
1. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma.
Chen Y; Liu X; Zheng D; Xu L; Hong L; Xu Y; Pan J
Magn Reson Imaging; 2014 Jul; 32(6):630-7. PubMed ID: 24703576
[TBL] [Abstract][Full Text] [Related]
2. Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: Value of dynamic contrast-enhanced 3.0 T MRI.
Zheng D; Chen Y; Liu X; Chen Y; Xu L; Ren W; Chen W; Chan Q
J Magn Reson Imaging; 2015 Jun; 41(6):1528-40. PubMed ID: 25136770
[TBL] [Abstract][Full Text] [Related]
3. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
4. Early assessment of induction chemotherapy response of nasopharyngeal carcinoma by pretreatment diffusion-weighted magnetic resonance imaging.
Zheng D; Chen Y; Chen Y; Xu L; Lin F; Lin J; Huang C; Pan J
J Comput Assist Tomogr; 2013; 37(5):673-80. PubMed ID: 24045239
[TBL] [Abstract][Full Text] [Related]
5. Early responses assessment of neoadjuvant chemotherapy in nasopharyngeal carcinoma by serial dynamic contrast-enhanced MR imaging.
Zheng D; Yue Q; Ren W; Liu M; Zhang X; Lin H; Lai G; Chen W; Chan Q; Chen Y
Magn Reson Imaging; 2017 Jan; 35():125-131. PubMed ID: 27587228
[TBL] [Abstract][Full Text] [Related]
6. Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma.
Hou J; Yu X; Hu Y; Li F; Xiang W; Wang L; Wang H; Lu Q; Zhang Z; Zeng W
Medicine (Baltimore); 2016 Aug; 95(35):e4320. PubMed ID: 27583847
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment Diffusion-Weighted MRI Can Predict the Response to Neoadjuvant Chemotherapy in Patients with Nasopharyngeal Carcinoma.
Zhang GY; Wang YJ; Liu JP; Zhou XH; Xu ZF; Chen XP; Xu T; Wei WH; Zhang Y; Huang Y
Biomed Res Int; 2015; 2015():307943. PubMed ID: 26413513
[TBL] [Abstract][Full Text] [Related]
9. Diffusion kurtosis imaging predicts neoadjuvant chemotherapy responses within 4 days in advanced nasopharyngeal carcinoma patients.
Chen Y; Ren W; Zheng D; Zhong J; Liu X; Yue Q; Liu M; Xiao Y; Chen W; Chan Q; Pan J
J Magn Reson Imaging; 2015 Nov; 42(5):1354-61. PubMed ID: 25873208
[TBL] [Abstract][Full Text] [Related]
10. The Role of Intravoxel Incoherent Motion MRI in Predicting Early Treatment Response to Chemoradiation for Metastatic Lymph Nodes in Nasopharyngeal Carcinoma.
Lu L; Li Y; Li W
Adv Ther; 2016 Jul; 33(7):1158-68. PubMed ID: 27294489
[TBL] [Abstract][Full Text] [Related]
11. Intravoxel incoherent motion MRI for predicting early response to induction chemotherapy and chemoradiotherapy in patients with nasopharyngeal carcinoma.
Xiao-ping Y; Jing H; Fei-ping L; Yin H; Qiang L; Lanlan W; Wei W
J Magn Reson Imaging; 2016 May; 43(5):1179-90. PubMed ID: 26540374
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study.
Fan WJ; Teng F; Luo YR; Yu W; Zhang Q; Lu YP; Ma L
Strahlenther Onkol; 2020 Jun; 196(6):530-541. PubMed ID: 32025803
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted imaging to differentiate metastatic from non-metastatic retropharyngeal lymph nodes in nasopharyngeal carcinoma.
Li H; Liu XW; Geng ZJ; Wang DL; Xie CM
Dentomaxillofac Radiol; 2015; 44(3):20140126. PubMed ID: 25430557
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
Yan DF; Zhang WB; Ke SB; Zhao F; Yan SX; Wang QD; Teng LS
BMC Cancer; 2017 Oct; 17(1):678. PubMed ID: 29020937
[TBL] [Abstract][Full Text] [Related]
16. The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
Wang L; Liu L; Han C; Liu S; Tian H; Li Z; Ren X; Shi G; Wang Q; Wang G
Radiother Oncol; 2016 Nov; 121(2):246-251. PubMed ID: 27838148
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary application of diffusion-weighted imaging with 3.0 T magnetic resonance scanner for nasopharyngeal carcinoma].
Liu K; Ouyang H; Zhou CW; Tao H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Apr; 32(2):200-4. PubMed ID: 20450553
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of 1.5-T diffusion-weighted MR imaging in detecting 5 to 10 mm metastatic cervical lymph nodes of nasopharyngeal carcinoma.
Jin GQ; Yang J; Liu LD; Su DK; Wang DP; Zhao SF; Liao ZL
Medicine (Baltimore); 2016 Aug; 95(32):e4286. PubMed ID: 27512841
[TBL] [Abstract][Full Text] [Related]
19. Value of magnetic resonance diffusion-weighted imaging for the prediction of radiosensitivity in nasopharyngeal carcinoma.
Hong J; Yao Y; Zhang Y; Tang T; Zhang H; Bao D; Chen Y; Pan J
Otolaryngol Head Neck Surg; 2013 Nov; 149(5):707-13. PubMed ID: 23884282
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer.
Makino H; Kato H; Furui T; Morishige K; Kanematsu M
J Obstet Gynaecol Res; 2014 Apr; 40(4):1098-104. PubMed ID: 24320754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
